BAYER AKTIENGESELLSCHAFT
Insider CIK 1144145 · CRSP 10% owner · AZTR 10% owner · ELAN 10% owner · PYXS · MGX 10% owner · IPSC 10% owner · SNTI 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SNTI Senti Biosciences, Inc. | C Conversion deriv | 2025-03-10 | 2025-03-12 | 2,222 | — | $0 | 0 | SEC↗ |
| SNTI Senti Biosciences, Inc. | C Conversion | 2025-03-10 | 2025-03-12 | 2,222,000 | — | $0 | 2,809,848 | SEC↗ |
| SNTI Senti Biosciences, Inc. | P Buy deriv | 2024-12-09 | 2024-12-11 | 3,333,000 | — | $0 | 3,330,000 | SEC↗ |
| SNTI Senti Biosciences, Inc. | P Buy deriv | 2024-12-09 | 2024-12-11 | 2,222 | — | $0 | 2,222 | SEC↗ |
| MGX Metagenomi, Inc. | C Conversion deriv | 2024-02-13 | 2024-02-15 | 2,062,387 | — | $0 | 0 | SEC↗ |
| MGX Metagenomi, Inc. | C Conversion deriv | 2024-02-13 | 2024-02-15 | 1,030,086 | — | $0 | 0 | SEC↗ |
| MGX Metagenomi, Inc. | C Conversion deriv | 2024-02-13 | 2024-02-15 | 890,671 | — | $0 | 0 | SEC↗ |
| MGX Metagenomi, Inc. | C Conversion deriv | 2024-02-13 | 2024-02-15 | 3,093,580 | — | $0 | 0 | SEC↗ |
| MGX Metagenomi, Inc. | C Conversion | 2024-02-13 | 2024-02-15 | 509,855 | — | $0 | 4,050,997 | SEC↗ |
| MGX Metagenomi, Inc. | C Conversion | 2024-02-13 | 2024-02-15 | 1,770,888 | — | $0 | 1,770,888 | SEC↗ |
| MGX Metagenomi, Inc. | C Conversion | 2024-02-13 | 2024-02-15 | 1,180,592 | — | $0 | 2,951,480 | SEC↗ |
| MGX Metagenomi, Inc. | C Conversion | 2024-02-13 | 2024-02-15 | 589,662 | — | $0 | 3,541,142 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-07-24 | 1,307,401 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-07-24 | 1,307,401 | — | $0 | 1,307,401 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | C Conversion deriv | 2021-10-13 | 2021-10-15 | 6,076,072 | — | $0 | 0 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | C Conversion deriv | 2021-10-13 | 2021-10-15 | 11,362,462 | — | $0 | 0 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | C Conversion | 2021-10-13 | 2021-10-15 | 2,742,338 | — | $0 | 2,742,338 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-23 | 26,143,790 | — | $0 | 0 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-23 | 3,862,813 | — | $0 | 0 | SEC↗ |
| IPSC Century Therapeutics, Inc. | P Buy | 2021-06-22 | 2021-06-23 | 750,000 | $20.00 | $15.00M | 12,675,838 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion | 2021-06-22 | 2021-06-23 | 1,535,238 | — | $0 | 11,925,838 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion | 2021-06-22 | 2021-06-23 | 10,390,600 | — | $0 | 10,390,600 | SEC↗ |
| ELAN Elanco Animal Health Inc | S Sale | 2020-12-03 | 2020-12-03 | 54,500,000 | $29.84 | $1.63B | 18,446,429 | SEC↗ |
| CRSP CRISPR Therapeutics AG | P Buy | 2018-01-05 | 2018-01-30 | 527,472 | $22.75 | $12.00M | 5,632,802 | SEC↗ |